Morning Market Losers

Zalicus ZLCS plummeted 71.61% to $1.33 after the company reported results from Phase 2 clinical trials of Z160 in chronic neuropathic pain. RadNet RDNT dropped 14.05% to $2.0199 after the company reported Q3 results. Ballantyne Strong BTN dropped 12.55% to $4.18 on Q3 results. Cirrus Logic CRUS dropped 12.04% to $19.57. Cirrus Logic shares have dropped 27.88% over the past 52 weeks, while the S&P 500 index has gained 28.30% in the same period.